Literature DB >> 21922265

Oguchi disease masked by retinitis pigmentosa.

Hiroko Sonoyama1, Kei Shinoda, Chie Ishigami, Yumi Tada, Hidenao Ideta, Ryuichi Ideta, Masayo Takahashi, Yozo Miyake.   

Abstract

The purpose of this study was to report a patient with Oguchi disease whose ophthalmological characteristics were masked by retinitis pigmentosa (RP). The method used in this study was case report. A 53-year-old man had a progressive decrease in his visual acuity and was diagnosed with RP because of night blindness, fundoscopic findings, ring scotoma, and extinguished single-flash electroretinograms (ERGs). However, a faint golden-yellowish reflex of the retina prompted us to make a more detailed examination of the fundus after a long period of dark adaptation, ERGs, and genetic analysis. Examinations showed the Mizuo-Nakamura phenomenon, relative intact photopic ERGs, and a SAG mutation, and the patient was diagnosed with RP associated with Oguchi disease. When RP accompanies Oguchi disease, the clinical characteristics of Oguchi disease might be masked. In such a situation, the correct diagnosis is difficult. However, careful analysis of clinical findings will suggest Oguchi disease, which can be confirmed by molecular genetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922265     DOI: 10.1007/s10633-011-9286-x

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  15 in total

1.  The photopic hill: a new phenomenon of the light adapted electroretinogram.

Authors:  N Wali; L E Leguire
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 2.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

3.  Two Indian siblings with Oguchi disease are homozygous for an arrestin mutation encoding premature termination.

Authors:  M Maw; G Kumaramanickavel; B Kar; S John; R Bridges; M Denton
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  Electrophysiological findings in patients with Oguchi's disease.

Authors:  Y Miyake; M Horiguchi; S Suzuki; M Kondo; A Tanikawa
Journal:  Jpn J Ophthalmol       Date:  1996       Impact factor: 2.447

5.  Oguchi disease with sectoral retinitis pigmentosa harboring adenine deletion at position 1147 in the arrestin gene.

Authors:  Y Nakamachi; M Nakamura; S Fujii; M Yamamoto; K Okubo
Journal:  Am J Ophthalmol       Date:  1998-02       Impact factor: 5.258

6.  Arrestin gene mutations in autosomal recessive retinitis pigmentosa.

Authors:  M Nakazawa; Y Wada; M Tamai
Journal:  Arch Ophthalmol       Date:  1998-04

7.  Oguchi disease: phenotypic characteristics of patients with the frequent 1147delA mutation in the arrestin gene.

Authors:  M Nakazawa; Y Wada; S Fuchs; A Gal; M Tamai
Journal:  Retina       Date:  1997       Impact factor: 4.256

8.  Visual function and gene analysis in a family with Oguchi's disease.

Authors:  M Yoshii; A Murakami; K Akeo; A Nakamura; M Shimoyama; Y Ikeda; Y Kikuchi; S Okisaka; K Yanashima; Y Oguchi
Journal:  Ophthalmic Res       Date:  1998       Impact factor: 2.892

9.  Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness.

Authors:  S Yamamoto; K C Sippel; E L Berson; T P Dryja
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

10.  Gene analysis and evaluation of the single founder effect in Japanese patients with Oguchi disease.

Authors:  Masamichi Saga; Yukihiko Mashima; Jun Kudoh; Yoshihisa Oguchi; Nobuyoshi Shimizu
Journal:  Jpn J Ophthalmol       Date:  2004 Jul-Aug       Impact factor: 2.447

View more
  6 in total

1.  A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease.

Authors:  Nadia K Waheed; Ahmed H Qavi; Sarah N Malik; Maleeha Maria; Moeen Riaz; Frans P M Cremers; Maleeha Azam; Raheel Qamar
Journal:  Mol Vis       Date:  2012-05-12       Impact factor: 2.367

2.  A non-stop S-antigen gene mutation is associated with late onset hereditary retinal degeneration in dogs.

Authors:  Orly Goldstein; Julie Ann Jordan; Gustavo D Aguirre; Gregory M Acland
Journal:  Mol Vis       Date:  2013-08-27       Impact factor: 2.367

3.  A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.

Authors:  Henri Leinonen; Elliot H Choi; Anthony Gardella; Vladimir J Kefalov; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

4.  Clinical Findings in Four Siblings with Genetically Proven Oguchi Disease.

Authors:  Cagri Ilhan; Mehmet Citirik; Mehmet Yasin Teke; Selda Celik Dulger
Journal:  J Curr Ophthalmol       Date:  2020-12-12

5.  A compound heterozygous mutation in the S-Antigen Visual Arrestin SAG gene in a Chinese patient with Oguchi type one: a case report.

Authors:  Zhen Deng; Fangli Fan; Danyan Tang; Yifeng Wu; Yujie Shu; Kunlin Wu
Journal:  BMC Ophthalmol       Date:  2022-03-04       Impact factor: 2.209

Review 6.  Genetic dissection of non-syndromic retinitis pigmentosa.

Authors:  Aarti Bhardwaj; Anshu Yadav; Manoj Yadav; Mukesh Tanwar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.